Skip to content
RDL Network logo
Depth of Response and MRD with Daratumumab Plus Lenalidomide and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in RRMM: POLLUX — Jesús F. San Miguel (2017) | RDL Network